← Leaderboards
Kim Marie Keeling
University Of Alabama At Birmingham
$762,562
Attributed
$1,130,062
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $367.5K · FY2014–17$500K$375K$250K$125K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$1,130,062 · 2
By mechanism
R21$1,130,062 · 2
Top collaborators
- David M Bedwell2 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- David M Bedwell$9,475,400
- Barry P Sleckman$19,849,738
- Steven Mark Rowe$18,443,646
- Kathryn E Oliver$1,612,583
Others in their field
Top investigators on “Mucopolysaccharidosis I”
- John H Wolfe · Children'S Hospital Of Philadelphia$12,246,305
- Chester B Whitley · University Of Minnesota Twin Cities$10,521,642
- Mark E Haskins · University Of Pennsylvania$9,740,854
- Srikanth Singamsetty · Phoenix Nest, Inc.$8,567,056
- Patricia I Dickson · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$7,738,239
- Douglas M McCarty · University Of North Carolina Chapel Hill$5,440,677
Research focus
Mucopolysaccharidosis ISeveritiesIn VivoMouse ModelPhenotypePublic Health RelevanceEmbryoIn VitroLengthMediatingMutationNonsense MutationPreventProteinsAmino AcidsEffectivenessGenesIntellectual Functioning DisabilityAttenuatedKnock-In MouseL-IduronidaseLysosomal Storage DiseasesMucopolysaccharidosis I HTissues
Grant awards (4)
Investigating the Effects of Reducing Nonsense-Mediated mRNA Decay Efficiency$174,562
R21 · FY2017 · OD · contact PI
Investigating the Effects of Reducing Nonsense-Mediated mRNA Decay Efficiency$220,500
R21 · FY2016 · OD · contact PI
New Nonsense Suppression Drugs to Treat MPS I$367,500
R21 · FY2015 · NS
New Nonsense Suppression Drugs to Treat MPS I$367,500
R21 · FY2014 · NS